Comparative study of the effects of regular insulin or ultra rapid acting insulin on postprandial hyperglycemia in type 2 diabetic patients treated with steroid

Comparative study of the effects of regular insulin or ultra rapid acting insulin on postprandial hyperglycemia in type 2 diabetic patients treated with steroid - Cross-over study of regular and ultra rapid acting insulin in steroid DM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012075

Enrollment

Registered

2013-10-19

Start date

2013-10-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

ultra rapid acting insulin three times a day regular insulin three times a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with FBS<=140mg/dl and 2-hour postprandial blood glucose <=250 mg/dl

Exclusion criteria

Exclusion criteria: 1)patients who have allergy to the medicine used in this study 2)patients with hypogycemia 3)severe kidney and liver disease 4)patients with proliferative retinopathy (except for post PC) 5)preganant or possible pregnant women

Design outcomes

Primary

Measure	Time frame
Area under the curve of postprandial hyperglycemia using CGM	—

Secondary

Measure	Time frame
frequency of hypoglycemia	—

Countries

Japan

Contacts

Public ContactAkio Kanazawa

Juntendo university graduate school of medicine Department of metabolism and endocrinology

akana@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026